AU2001277753A1 - Phosphonocephem compound - Google Patents

Phosphonocephem compound

Info

Publication number
AU2001277753A1
AU2001277753A1 AU2001277753A AU7775301A AU2001277753A1 AU 2001277753 A1 AU2001277753 A1 AU 2001277753A1 AU 2001277753 A AU2001277753 A AU 2001277753A AU 7775301 A AU7775301 A AU 7775301A AU 2001277753 A1 AU2001277753 A1 AU 2001277753A1
Authority
AU
Australia
Prior art keywords
compound
phosphonocephem
phosphonocephem compound
formula
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001277753A
Inventor
Shohei Hashiguchi
Yuji Iizawa
Tomoyasu Ishikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26598061&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2001277753(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU2001277753A1 publication Critical patent/AU2001277753A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

A disodium salt of a compound represented by the formula:
AU2001277753A 2000-08-10 2001-08-10 Phosphonocephem compound Abandoned AU2001277753A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000247966 2000-08-10
JP2000-247966 2000-08-10
JP2000-354959 2000-11-21
JP2000354959 2000-11-21
PCT/JP2001/006904 WO2002014333A1 (en) 2000-08-10 2001-08-10 Phosphonocephem compound

Publications (1)

Publication Number Publication Date
AU2001277753A1 true AU2001277753A1 (en) 2002-02-25

Family

ID=26598061

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001277753A Abandoned AU2001277753A1 (en) 2000-08-10 2001-08-10 Phosphonocephem compound

Country Status (13)

Country Link
US (2) US6906055B2 (en)
EP (2) EP1310502B1 (en)
KR (1) KR100826487B1 (en)
CN (1) CN1189471C (en)
AT (1) ATE431827T1 (en)
AU (1) AU2001277753A1 (en)
CA (1) CA2418614C (en)
CY (1) CY1109313T1 (en)
DE (1) DE60138760D1 (en)
DK (1) DK1310502T3 (en)
ES (1) ES2323759T3 (en)
PT (1) PT1310502E (en)
WO (1) WO2002014333A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1189471C (en) * 2000-08-10 2005-02-16 武田药品工业株式会社 Phosphonocephem compound
AT501931B1 (en) * 2004-12-10 2007-08-15 Chemiefaser Lenzing Ag CELLULOSE STAPLE FIBER AND ITS USE
US20070238719A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070249577A1 (en) * 2005-05-10 2007-10-25 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
US20070238720A1 (en) * 2005-05-10 2007-10-11 Hopkins Scott J Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
CA2700263A1 (en) * 2007-09-21 2009-03-26 Forest Laboratories Holdings Limited Soluble dosage forms containing cephem derivatives suitable for parenteral administration
AU2009285632A1 (en) * 2008-08-28 2010-03-04 Astrazeneca Ab Compositions and methods of treatment comprising ceftaroline
WO2010096798A1 (en) * 2009-02-23 2010-08-26 Forest Laboratories Holdings Limited Novel cephem compounds useful for the treatment of bacterial infections
KR20120083344A (en) * 2009-09-21 2012-07-25 아스트라제네카 아베 Compositions and methods for treating bacterial infections using ceftaroline
FR2951171A1 (en) 2009-10-09 2011-04-15 Novexel NOVEL SODIUM SALT OF A CRYSTALLIZED ENANTIOMER AZABICYCLIC COMPOUND AND NOVEL POLYMORPHIC AND PSEUDOPOLYMORPHIC FORMS AND THEIR PREPARATION
JP6023800B2 (en) 2011-06-17 2016-11-09 アストラゼネカ アクチボラグ Process for producing a heterocyclic compound containing trans-7-oxo-6- (sulfooxy) -1,6-diazabicyclo [3,2,1] octane-2-carboxamide and a salt thereof
CN103889979B (en) * 2011-09-09 2017-03-01 桑多斯股份公司 For preparing the new method of Ceftaroline Fosamil
US20140350240A1 (en) 2011-12-07 2014-11-27 Ranbaxy Laboratories Limited Process for preparing ceftaroline salts or hydrates thereof
CA2887391C (en) * 2012-10-19 2019-06-18 Sandoz Ag Novel process for preparing ceftaroline fosamil
CN102977124B (en) * 2012-12-13 2014-11-26 山东诚创医药技术开发有限公司 Preparation method of 7beta-[(phenylacetyl) amino]-3-[4-(1-methyl-4-pyridine onium)-2-thiothiazole]-3-cephem-4-benzhydryl carboxylate
JP2016501903A (en) * 2012-12-20 2016-01-21 サンド・アクチエンゲゼルシヤフト A new crystalline form of ceftaroline fosamil.
EP3107923B1 (en) 2014-02-21 2021-11-03 Shanghai MicuRx Pharmaceutical Co., Ltd. Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration
WO2016008393A1 (en) * 2014-07-14 2016-01-21 正大天晴药业集团股份有限公司 Ceftaroline fosamil amino acid salt and crystal thereof
CN104177408B (en) * 2014-09-12 2016-09-07 衡水衡林生物科技有限公司 (Z) preparation method of-2-(5-dichlor-phosphoryl amino-1,2,4-thiadiazoles-3-base)-2-ethoxyimino chloroacetic chloride
EP3212238A1 (en) 2014-10-28 2017-09-06 Sandoz AG Pharmaceutical composition consisting of ceftaroline fosamil acetic acid solvate particles and arginine particles, both having a specific particle size distribution
WO2016128580A1 (en) * 2015-02-13 2016-08-18 Fresenius Kabi Anti-Infectives Srl Cephalosporin intermediate and process for its preparation
CN104725425B (en) * 2015-04-09 2017-01-04 山东罗欣药业集团股份有限公司 A kind of preparation method of Ceftaroline Fosamil
CN104892674B (en) * 2015-06-18 2017-01-18 河北大学 Preparation method of ceftaroline fosamil
CN107216353B (en) * 2016-03-21 2020-05-19 山东诚创医药技术开发有限公司 Method for refining ceftaroline fosamil imidazole salt
CN106565784B (en) * 2016-10-31 2019-02-26 瑞阳制药有限公司 The purification process of Ceftaroline Fosamil disodium salt
CN106749410B (en) * 2016-12-02 2018-06-12 齐鲁安替制药有限公司 A kind of preparation method of Ceftaroline Fosamil in high yield
CN107325114B (en) * 2017-07-04 2019-06-11 吉林省爱诺德生物工程有限公司 A kind of preparation method of Ceftaroline Fosamil intermediate
CN108440566A (en) * 2018-01-04 2018-08-24 北京满格医药科技有限公司 A kind of process for purification of Ceftaroline Fosamil intermediate 1
CN110872322B (en) * 2018-08-29 2022-08-02 上海博志研新药物技术有限公司 Preparation method of cefaloside acetate monohydrate and intermediate thereof
KR102205496B1 (en) * 2019-02-27 2021-01-21 국제약품(주) Manufacturing method of intermediate for preparation of cephalosporin derivative and ceftaroline fosamil metal salt manufactured thereby
CN113336775A (en) * 2021-06-21 2021-09-03 湖北凌晟药业有限公司 Synthesis method of cefotaxime intermediate
CN115417886A (en) * 2022-09-19 2022-12-02 瑞阳制药股份有限公司 Efficient preparation method of cephalosporin medicine intermediate

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4142059A (en) * 1976-04-02 1979-02-27 Eli Lilly And Company Spray drying sodium and potassium 2-ethylhexanoate
AU5781396A (en) * 1995-05-29 1996-12-18 Takeda Chemical Industries Ltd. Cephem compounds, their production and use
JP3927262B2 (en) 1995-07-19 2007-06-06 武田薬品工業株式会社 Cephem compound, production method thereof and antibacterial composition
TW473479B (en) * 1997-12-19 2002-01-21 Takeda Chemical Industries Ltd Phosphonocephem derivatives, their production and use
JP2000247966A (en) 1999-03-01 2000-09-12 Wakunaga Pharmaceut Co Ltd Production of 2,6-dialkyl-gamma-pyrone derivative and intermediate therefor
US6050882A (en) 1999-06-10 2000-04-18 Applied Materials, Inc. Carrier head to apply pressure to and retain a substrate
CN1189471C (en) * 2000-08-10 2005-02-16 武田药品工业株式会社 Phosphonocephem compound

Also Published As

Publication number Publication date
KR100826487B1 (en) 2008-05-02
PT1310502E (en) 2009-07-31
ES2323759T3 (en) 2009-07-24
EP1310502B1 (en) 2009-05-20
CN1462275A (en) 2003-12-17
US20040023943A1 (en) 2004-02-05
EP2020416A1 (en) 2009-02-04
ATE431827T1 (en) 2009-06-15
EP1310502A1 (en) 2003-05-14
WO2002014333A1 (en) 2002-02-21
EP1310502A4 (en) 2007-08-01
CA2418614A1 (en) 2003-02-04
US20050176697A1 (en) 2005-08-11
CA2418614C (en) 2008-06-10
US6906055B2 (en) 2005-06-14
CY1109313T1 (en) 2014-07-02
US7419973B2 (en) 2008-09-02
DK1310502T3 (en) 2009-09-07
CN1189471C (en) 2005-02-16
DE60138760D1 (en) 2009-07-02
KR20030022891A (en) 2003-03-17

Similar Documents

Publication Publication Date Title
AU2001277753A1 (en) Phosphonocephem compound
HK1069395A1 (en) Phthalazinone derivatives 2,3
TW200738672A (en) Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
SI1385514T1 (en) Spiroindene and spiroindane compounds
CY1113657T1 (en) NEW PRODUCERS OF BENZOFFAINE OR SALTS
AU7862794A (en) 2,3-diaminopropionic acid derivative
EP1380564A4 (en) Binaphtol derivative and process for producing the same
ZA200108124B (en) Pharmaceutical compounds.
WO2002076918A8 (en) NF-λB INHIBITOR CONTAINING SUBSTITUTED BENZOIC ACID DERIVATIVE AS ACTIVE INGREDIENT
DE69621469D1 (en) Phenylpiperidine compounds
EP0924199A4 (en)
IL154014A0 (en) Process for the preparation of 2-aminoethylpyridines
DOP2002000371A (en) PHENYL-HETEROCICLIL-ETERES
AU2002214325A1 (en) Process for producing carbapenem-type antibacterial
TR200400293T4 (en) Synthesis of water-soluble 9-dihydro-paclitaxel derivatives of 9-dihydro-13-acetylbaccatin III.
AU5106100A (en) Antifucoidan antibody
AU2003248059A1 (en) NOVEL Alpha-KETOAMIDE DERIVATIVE AND USE THEREOF
GB9921578D0 (en) Omeprazole synthesis
AU4022493A (en) 5-amino-2-phenoxysulfonanilide compound
EP0721957A4 (en) Compound ge3
EP0659752A4 (en)
ES2164258T3 (en) CARBAMOILMETILUREA DERIVATIVES PREPARATION PROCEDURE.
AU2002360015A1 (en) 2-substituted vitamin d derivatives